Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Presplit high of almost $50?

<< Previous

Bullboard Posts

Next >>

Comment by ValueInvestor8on Dec 03, 2010 12:59pm

180 Views

Post# 17796599

RE: RE: Presplit high of almost $50?

Thanks,

I understand that charts reflect the split. Just saying it was still a far way to fall. Anyway I'm in. Think there is a lot of potential in their assets. The chart looks good. I apologize to the bagholders. Look on the brightside, now it looks undervalued.

Time will tell.

GLTA

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 12, 2024